Methenamine hippurate (brand name Cystohipp©) has been launched in Germany
EQL’s key product methenamine hippurate has now been launched in Germany by EQL’s license partner Dr Pfleger under the EQL-owned brand Cystohipp[©].
Media
Here you can take part in regulatory and non-regulatory press releases and presentations.
Read More
Press Releases
Year-end Report April 2025 - March 2026
Regulatory
During the quarter, sales rose to SEK 120.2 million, an increase of 6% from SEK 113.3 million in the previous year. Growth for next year negatively impacted by launch delays, but long-term outlook ...
EQL Pharma in process of recruiting new Chief Supply Chain Officer (CSCO)
EQL Pharma is recruiting a new CSCO with a clear CMO/CDMO background. This means that the current Chief Supply Chain Officer (CSCO) Magnus Erreth will leave his position. Magnus has been active in ...